Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase1, Phase2, Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Dallas TX, Houston TX, Memphis TN, St Louis MO,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 0 - 25

Code: NCT04094610

Phase1, Phase2, Recruiting

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

for
Medulloblastoma
Location: Dallas TX, Fort Worth TX, Houston TX, Memphis TN,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 4

Code: NCT05535166

Phase2, Recruiting

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Dallas TX, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 6 - 29

Code: NCT04678427

Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Dallas TX, Austin TX, Denver CO, Chicago IL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm,
Location: Dallas TX, Duarte CA, The Bronx NY, Portland OR,
Sponsor: Eureka Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04864054

Phase1, Phase2, Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

for
Germ Cell Tumor
Location: Dallas TX, San Antonio TX, Corpus Christi TX,
Sponsor: University of Sydney

Sex: All

Age: 11 - 50

Code: NCT02582697

Phase3, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Dallas TX, Springdale AR, Denver CO, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase2, Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Dallas TX, Houston TX, Denver CO, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase3, Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Dallas TX, Denison TX, San Antonio TX, Cordova TN,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase3, Recruiting

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Irving TX, Oklahoma City OK, Houston TX, St Louis MO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Irving TX, Shreveport LA, Oklahoma City OK,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

for
Cancer
Location: Irving TX, Franklin TN, Jacksonville FL
Sponsor: Center for Biomedical Research, LLC

Sex: All

Age: 0+

Code: NCT02070328

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Dallas TX, Oklahoma City OK, Houston TX, Tulsa OK,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

for
Pemphigus Vulgaris
Location: Dallas TX, Houston TX, Iowa City IA, Chicago IL,
Sponsor: Cabaletta Bio

Sex: All

Age: 18+

Code: NCT04422912

Phase1, Phase2, Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Dallas TX, McKinney TX, Houston TX, San Antonio TX,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase3, Recruiting
New

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA, East Brunswick NJ
Sponsor: Fortvita Biologics (USA)Inc.

Sex: All

Age: 18+

Code: NCT06349408

Phase1, Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Irving TX, Birmingham AL, Knoxville TN, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase1, Phase2, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irving TX, Houston TX, Memphis TN, Grand Island NE,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Irving TX, Tyler TX, Houston TX, New Orleans LA,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase1, Recruiting